Herpes simplex virus type 2 (HSV-2) is widely distributed through the human population, infecting more than 500 million people globally [1]. Although typically causing mild diseases this virus may be responsible for severe infections, mainly in immunocompromised patients. Currently, there is a number of systemic antiviral agents against herpesvirus, the most commonly used being acyclovir and related drugs. Howe...